Development of Molecularly Targeted Ultrasound Contrast Agents for Prostate Cancer Imaging using Bioorthogonal Chemistry Grant uri icon

  •  
  • Overview
  •  
  • Affiliation
  •  
  • View All
  •  

date/time interval

  • April 1, 2016 - March 31, 2019

total award amount

  • CAD 261250